Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE III 10 versus FREAMINE III 3 W ELECTROLYTES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE III 10 versus FREAMINE III 3 W ELECTROLYTES.
FREAMINE III 10% vs FREAMINE III 3% W/ ELECTROLYTES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FREAMINE III 10% is a parenteral amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in patients unable to tolerate oral or enteral nutrition.
Provides essential and non-essential amino acids for protein synthesis, maintaining nitrogen balance, and supporting metabolic functions. Electrolytes help maintain acid-base balance and osmotic pressure.
Intravenous administration as part of parenteral nutrition. Typical adult dose: 0.8-1.5 g amino acids/kg/day, infused continuously over 24 hours.
Administered intravenously. Typical adult dose: 500-1000 mL/day (15-30 g amino acids) infused at a rate not exceeding 0.1 g/kg/hour. Frequency: continuous or intermittent infusion as part of parenteral nutrition.
None Documented
None Documented
Component-dependent: free amino acids t1/2 ~15–30 min; urea cycle intermediates ca. 2 h.
Variable; based on individual amino acid components (alanine ~2.3h, glycine ~1.5h, etc.); clinical context: continuous infusion achieves steady state within 8-12h
Primarily renal; amino acids and nitrogenous waste products are excreted as urea and other metabolites. <5% fecal.
Renal excretion of amino acid nitrogen as urea (85-90%) and other nitrogenous wastes; minimal biliary/fecal (<5%)
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid